[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-464811-105":59,"doc-detail-464811-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibition-of-tumor-microenvironment-driven-jak-stat-signaling-enhances-response-to-arginine-deprivation-therapy-in-triple-negative-breast-cancer","Inhibition of Tumor Microenvironment-Driven JAK-STAT Signaling Enhances Response to Arginine Deprivation Therapy in Triple-Negative Breast Cancer","","Argininosuccinate synthetase 1 (ASS1) expression and arginine availability shape tumor fitness and govern immune interactions within the tumor microenvironment (TME). In an orthotopic triple-negative breast cancer (TNBC) model, arginine deprivation increases tumor reliance on the TME for survival. Mechanistically, fibroblasts sustain viability through arginine supply, while macrophages and stromal cues activate JAK-STAT signaling to promote survival. JAK-STAT gene signatures correlate with ASS1 levels in human TNBC datasets, and combined JAK inhibition plus arginine deprivation markedly suppresses tumor growth, identifying a targetable stromal–immune circuit.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-tumor-microenvironment-driven-jak-stat-signaling-enhances-response-to-arginine-deprivation-therapy-in-triple-negative-breast-cancer/464811/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-tumor-microenvironment-driven-jak-stat-signaling-enhances-response-to-arginine-deprivation-therapy-in-triple-negative-breast-cancer/464811.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does arginine deprivation affect TNBC growth in different settings?","Question",{"text":112,"@type":113},"Arginine depletion suppresses TNBC cell growth in vitro but not in vivo, indicating a TME-mediated supply of arginine and activation of JAK-STAT signaling in living systems.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the relationship between ASS1 expression and JAK-STAT in TNBC?",{"text":117,"@type":113},"ASS1 expression in human TNBC tumors correlates with JAK-STAT gene expression, and the study reports concordant correlations across human TNBC datasets.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does combining JAK inhibition with arginine deprivation reduce tumor growth?",{"text":121,"@type":113},"The combination significantly suppresses tumor growth by disabling a TME-driven survival mechanism, where fibroblasts provide arginine and stromal–immune cues activate JAK-STAT signaling.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},464811,1790834903,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Article  \nInhibition of Tumor Microenvironment-Driven JAK-STAT Signaling Enhances Response to Arginine Deprivation Therapy in Triple-Negative Breast Cancer  \nHila Tishler 1, Shahar Ziman 1, Kuoyuan Cheng 2, Kun Wang 3, Neel Sanghvi 2, Lital Adler 1, Gil Stelzer 4, Hillary Maniriho 5, Bareket Dassa 4, Elizabeta Bab-Dinitz 1, Michal Levi 1, Sivan Galai 1, Omer Goldman 1, Yarden Ariav 1, Naama Darzi 1, Saar Ezagouri 1, Nitsan Nimni 1, Nataly Rosenfeld 1, Ron Rotkopf 4, Alexander Brandis 4, Tevie Mehlman 4, Roni Oren 6, Mirie Zerbib 6, Yuri Kuznetsov 6, Sara Donzelli 7, Giovanni Blandino 7, Rony Seger 8, Eytan Ruppin 2 and Ayelet Erez 1, *  \nAcademic Editors: Parash Prasad, Snehasis R. Mishra and J.  \nDinny Graham  \nReceived: 14 November 2025  \nRevised: 11 December 2025  \nAccepted: 15 December 2025  \nPublished: 23 December 2025  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Molecular Cell Biology, Weizmann Institute of Science, P.O. Box 26, Rehovot 76100, Israel; [hila.tishler@weizmann.ac.il](hila.tishler@weizmann.ac.il) (H.T.); [shahar.ziman@weizmann.ac.il](shahar.ziman@weizmann.ac.il) (S.Z.); [lital.adler@weizmann.ac.il](lital.adler@weizmann.ac.il) (L.A.); [elizabeta.bab-dinitz@weizmann.ac.il](elizabeta.bab-dinitz@weizmann.ac.il) (E.B.-D.); [sivangalai@gmail.com](sivangalai@gmail.com) (S.G.); [omer.goldman@metabocure.com](omer.goldman@metabocure.com) (O.G.); [yarden.ariav@weizmann.ac.il](yarden.ariav@weizmann.ac.il) (Y.A.); [naama.darzi@weizmann.ac.il](naama.darzi@weizmann.ac.il) (N.D.); [sezagouri@gmail.com](sezagouri@gmail.com) (S.E.); [nitsan.nimni@weizmann.ac.il](nitsan.nimni@weizmann.ac.il) (N.N.); [nataly.rosenfeld@weizmann.ac.il](nataly.rosenfeld@weizmann.ac.il) (N.R.)  \n2 Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; [cheng.ky@hotmail.com](cheng.ky@hotmail.com) (K.C.); [neel.sanghvi@nih.gov](neel.sanghvi@nih.gov) (N.S.); [eyruppin@gmail.com](eyruppin@gmail.com) (E.R.)  \n3 Departments of Comparative Biosciences and Bioengineering, The Cancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, IL 61802, USA; [kwang222@illinois.edu](kwang222@illinois.edu)  \n4 Department of Life Sciences Core Facilities, Weizmann Institute of Science, P.O. Box 26, Rehovot 76100, Israel; [gil.stelzer@weizmann.ac.il](gil.stelzer@weizmann.ac.il) (G.S.); [bareket.dassa@weizmann.ac.il](bareket.dassa@weizmann.ac.il) (B.D.); [ron.rotkopf@weizmann.ac.il](ron.rotkopf@weizmann.ac.il) (R.R.); [alexander.brandis@weizmann.ac.il](alexander.brandis@weizmann.ac.il) (A.B.); [tevie.mehlman@weizmann.ac.il](tevie.mehlman@weizmann.ac.il) (T.M.)  \n5 Felsenstein Medical Research Center, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Petah Tikva 49100, Israel; [hillarym@mail.tau.ac.il](hillarym@mail.tau.ac.il)  \n6 Department of Veterinary Resources, Weizmann Institute of Science, P.O. Box 26, Rehovot 76100, Israel; [roni.oren@weizmann.ac.il](roni.oren@weizmann.ac.il) (R.O.); [mirie.zerbib@weizmann.ac.il](mirie.zerbib@weizmann.ac.il) (M.Z.); [yuri.kuznetsov@weizmann.ac.il](yuri.kuznetsov@weizmann.ac.il) (Y.K.)  \n7 Translational Oncology Research Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Regina Elena National Cancer Institute, 00144 Rome, Italy; [sara.donzelli@ifo.it](sara.donzelli@ifo.it) (S.D.); [giovanni.blandino@ifo.it](giovanni.blandino@ifo.it) (G.B.)  \n8 Department of Immunology and Regenerative Biology, Weizmann Institute of Science,  \nP.O. Box 26, Rehovot 76100, Israel; [rony.seger@weizmann.ac.il](rony.seger@weizmann.ac.il)  \n* Correspondence: [ayelet.erez@weizmann.ac.il](ayelet.erez@weizmann.ac.il); Tel.: +972-8-9343714  \nHighlights  \nWhat are the main findings?  \n• Arginine depletion suppresses TNBC cell growth in vitro but not in vivo","cbCaih6OZX8unNfA","https://ap.wps.com/l/cbCaih6OZX8unNfA","pdf",3137607,18,"English","# Highlights\n## What are the main findings?\n## What are the implications of the main findings?\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"How does arginine deprivation affect TNBC growth in different settings?\",\"answer\":\"Arginine depletion suppresses TNBC cell growth in vitro but not in vivo, indicating a TME-mediated supply of arginine and activation of JAK-STAT signaling in living systems.\"},{\"question\":\"What is the relationship between ASS1 expression and JAK-STAT in TNBC?\",\"answer\":\"ASS1 expression in human TNBC tumors correlates with JAK-STAT gene expression, and the study reports concordant correlations across human TNBC datasets.\"},{\"question\":\"Why does combining JAK inhibition with arginine deprivation reduce tumor growth?\",\"answer\":\"The combination significantly suppresses tumor growth by disabling a TME-driven survival mechanism, where fibroblasts provide arginine and stromal–immune cues activate JAK-STAT signaling.\"}]","Inhibition of Tumor Microenvironment-Driven JAK-STAT Signaling Enhances Response to Arginine Deprivation Therapy in Triple-Negative Breast Cancer | PDF",1790768687,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/c50a0622682e0325cab935b38a028ecc.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/bde3e47ff09867b97a73cbcd32cc9245.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/78c66645721130058f1fefc387227f4a.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/d72943c3e653d08a5fc9092694ca03de.webp",980,1385]